Survie globale des patients atteints de CBNPC EGFRm+ recevant la séquence de traitement afatinib suivi d’osimertinib : analyse actualisée de l’étude GioTag
Year: 2020
Type: article
Study design: Observational Study
Institutions: Institut Curie, Otto Wagner Hospital, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", University of Calgary, Chang Gung Memorial Hospital, National University Hospital, National Taiwan University Hospital, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Boehringer Ingelheim (Germany), University of Ljubljana
Language: French
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2997402904
